Your session is about to expire
← Back to Search
Retinal Imaging with Low-Cost OCT Device vs Commercial OCT Device for Optical Coherence Tomography
Study Summary
This trial is testing a new OCT device to see if it takes images of the retina that are as good as a commercial device.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have eye conditions like glaucoma, corneal injury, or diabetes affecting my vision.I have had eye surgery that was not for cataracts.
- Group 1: OCT Imaging
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is there presently any capacity to join this investigation?
"As of now, this clinical trial is not actively enrolling patients. According to the data on clinicaltrials.gov, which was last edited on November 16th 2022, recruitment for this study has temporarily ceased; however, there are other trials presently searching for participants."
Who is qualified to volunteer for this medical research program?
"This medical experiment is seeking 12 individuals aged between 18 and 85, who have a documented occurrence of retinal optical coherence tomography. Additionally, the participants must be able to provide valid informed consent."
Is the age threshold for this research study less than 55?
"This research initiative is open to individuals over 18 and below 85 years of age."
Share this study with friends
Copy Link
Messenger